Table 2.
Indications for mastectomy regardless of response to neoadjuvant treatment
| Inflammatory disease (cT4d) Multicentric disease Patient choice BRCA1/BRCA2 mutation carriers wanting reduction risk surgery |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.